$0.68-0.04 (-5.00%)
Allurion Technologies Inc. (ALUR) is a Medical/Dental Instruments company listed on NYSE. In the last 30 days Quantisnow tracked 1 wire item for ALUR, including 1 press release or news item. The most recent was published Oct 13, 2026.
Price$0.68+0.00 (+0.00%)
2026-07-302026-10-30
News · 26 weeks14+100%
2026-05-102026-11-01
Mix490d
- Other3(75%)
- SEC Filings1(25%)
Latest news
25 items- SECSEC Form 25-NSE filed by Allurion Technologies Inc.25-NSE - ALLURION TECHNOLOGIES, INC. (0001964979) (Subject)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.SCHEDULE 13D/A - ALLURION TECHNOLOGIES, INC. (0001964979) (Subject)
- SECAllurion Technologies Inc. filed SEC Form 8-K: Leadership Update8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- SECSEC Form NT 10-Q filed by Allurion Technologies Inc.NT 10-Q - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- SECAllurion Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.SCHEDULE 13D/A - ALLURION TECHNOLOGIES, INC. (0001964979) (Subject)
- INSIDERLarge owner Rtw Investments, Lp disposed of 392,766 shares (SEC Form 4)4 - ALLURION TECHNOLOGIES, INC. (0001964979) (Issuer)
- SECAllurion Technologies Inc. filed SEC Form 8-K: Leadership Update8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- SECAllurion Technologies Inc. filed SEC Form 8-K: Leadership Update8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- SECAllurion Technologies Inc. filed SEC Form 8-K: Leadership Update8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- SECAllurion Technologies Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- PRAllurion Advances Plan to Re-ListAllurion Technologies, Inc. (OTCQB:ALUR), a pioneer in metabolically healthy weight loss, today announced a 1-for-15 reverse stock of its outstanding common stock intended to support regaining compliance with the continued listing requirements of the New York Stock Exchange (the "NYSE") or initial listing requirements of the NYSE American. Allurion continues to actively engage with national exchanges and is advancing its re-listing strategy as part of a comprehensive plan to strengthen its capital markets positioning. "We have had a constructive and collaborative dialogue with the national exchanges throughout this process, and we remain focused on meeting all requirements necessary to
- PRAllurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth MomentumAllurion Technologies, Inc. (OTCQB:ALUR), a pioneer in metabolically healthy weight loss, today announced successful early traction in the launch of the Allurion Program in the United States, marked by strong clinical outcomes, rapid account growth, high re-order rates, and performance exceeding internal expectations. First shipments of the Allurion Smart Capsule were completed in April, with the first U.S. patients treated that same month. Early clinical outcomes have been highly encouraging, with patients losing between 8–11% of their total body weight in just the first four weeks, reinforcing the program's potential to deliver rapid, meaningful weight loss without surgery or invasive p
- SECAllurion Technologies Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- SECSEC Form 10-K filed by Allurion Technologies Inc.10-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- SECAllurion Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.SCHEDULE 13D/A - ALLURION TECHNOLOGIES, INC. (0001964979) (Subject)
- SECSEC Form 8-K filed by Allurion Technologies Inc.8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- PRAllurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSECompany's recent FDA approval catalyzes plan to regain compliance with listing requirements of NYSE or another exchange; shares of common stock expected to continue trading on NYSE during appeal process Allurion Technologies, Inc. (the "Company") (NYSE:ALUR), a pioneer in metabolically healthy weight loss, has received notice from the New York Stock Exchange (NYSE) that it intends to initiate delisting proceedings against Allurion after the Company was unable to demonstrate that it had regained compliance with Section 802.01B of the Listed Company Manual requiring listed companies to maintain either (i) at least $50 million in stockholders' equity or (ii) at least $50 million in total mar
- SECAllurion Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- PRAllurion Announces Exercise of Warrants for $3.0 Million in Gross ProceedsAllurion Technologies, Inc. (NYSE:ALUR) (the "Company" or "Allurion"), a pioneer in metabolically healthy weight loss, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,659,565 shares of common stock, issued by the Company on January 27, 2025 (the "January 2025 Warrants"), February 20, 2025 (the "February 2025 Warrants") and November 12, 2025 (the "November 2025 Warrants" and together with the January 2025 Warrants and the February 2025 Warrants, the "Existing Warrants"), at a reduced exercise price of $1.15 per share. The shares of common stock issuable upon exercise of the January 2025 Warra
- SECAllurion Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ALLURION TECHNOLOGIES, INC. (0001964979) (Filer)
- PRAllurion Receives U.S. FDA ApprovalApproval provides Allurion with access to approximately 80 million Americans with obesity Allurion Technologies, Inc. (NYSE:ALUR), a pioneer in metabolically healthy weight loss, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval (PMA) application for the Allurion Gastric Balloon System, featuring the Allurion Smart Capsule. "Today's approval is a watershed moment for Allurion and for obesity care in the United States," said Dr. Shantanu Gaur, Founder and Chief Executive Officer. "Our goal is to deliver patients metabolically healthy weight loss by helping them lose weight, keep it off, and maintain muscle. The Allurion Smart Capsule off
- INSIDERGibbons Brendan M. decreased direct ownership by 15% to 10,408 units (SEC Form 5)5 - ALLURION TECHNOLOGIES, INC. (0001964979) (Issuer)
- INSIDERBuch Ojas decreased direct ownership by 17% to 10,223 units (SEC Form 5)5 - ALLURION TECHNOLOGIES, INC. (0001964979) (Issuer)
ALUR FAQ
6 questionsWhat is the latest news on ALUR?
In the last 30 days Quantisnow tracked 1 wire item for ALUR: 1 press release or news item. The most recent was published on October 13, 2026.Where does ALUR stock trade?
Allurion Technologies Inc. (ALUR) is listed on NYSE.What sector and industry is ALUR in?
Allurion Technologies Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about ALUR?
Allurion Technologies Inc. has had 4 recent analyst actions on file. The most recent action was from Chardan Capital Markets: Neutral on 2024-11-14. Recent price targets range from $200.00 to $500.00.What companies are similar to ALUR?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare ALUR side-by-side with any of them on Quantisnow.How can I track ALUR on Quantisnow?
Quantisnow aggregates Allurion Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ALUR to receive live email and push alerts on every new disclosure.